<i>In Vitro</i> and <i>In Vivo</i> Activities of Contezolid (MRX-I) against Mycobacterium tuberculosis

Carolyn Shoen, Michelle S DeStefano, Barry Hafkin, Michael H. Cynamon

Antimicrobial Agents and Chemotherapy · 2018 · 65 citations · 8 references

DOIFull text

Open access

Concepts

Abstract

ABSTRACT The in vitro activity of contezolid (MRX-I) against clinical isolates of Mycobacterium tuberculosis was evaluated using a microtiter broth dilution assay. MRX-I was as effective as linezolid (LZD) in vitro . MRX-I and LZD were subsequently studied in BALB/c mice infected intranasally with M. tuberculosis Erdman. MRX-I and LZD at 100 mg/kg significantly reduced the bacterial load in lungs compared to the untreated early and late controls.

References

8